A proposed rule from the Office of Management and Budget to revise the federal grantmaking process is drawing widespread opposition from across multiple industries. Members of the medical research community warn the additional red tape will only serve to impede U.S. biomedical research. The Office of Management and Budget published a proposed rule in May that would, among several actions, instate a pre-issuance…
